Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy

Diabetes Technology and Therapeutics

Volumn 12, Issue 10, 2010, Pages 809-813

  Kung, Wan Ju ^a,b   Lin, Ching Chiang ^b   Liu, Shyh Hwa ^a   Chaung, Hso Chi ^a  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TAIWAN; URINE LEVEL;

ADULT; AGED; CHEMOKINE CCL2; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENETIC ASSOCIATION STUDIES; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957943580     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0085     Document Type: Article

References (23)

1. Freedman BI, Bowden DW, Rich SS, Appel RG: Genetic initiation of hypertensive and diabetic nephropathy. Am J Hypertens 1998;11:251-257.
2. Wang Y, Ng MC, So WY, Ma R, Ko GT, Tong PC, Chan JC: Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients. Nephrol Dial Transplant 2005;20:2733-2738.
3. Tesch GH: MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 2008;294:F697-F701.
4. Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY: Interleukin-10- 592C/A,-819C/T and-1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clin Endocrinol (Oxf) 2009; 70:401-407.
5. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ: Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002;2:560-567.
6. Tegoshi H, Hasegawa G, Obayashi H, Nakano K, Kitagawa Y, Fukui M, Matsuo S, Deguchi M, Ohta M, Nishimura M, Nakamura N, Yoshikawa T: Polymorphisms of interferongamma gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type I diabetes. Hum Immunol 2002;63:121-128.
7. Chang YH, Huang CN, Wu CY, Shiau MY: Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol 2005;66:1258-1263.
8. Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, Tassi V, Lauro R, Perticone F, Sesti G: Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 2006;55:1529-1533.
9. Weger M, Steinbrugger I, El-Shabrawi Y, Wegscheider BJ, Weger W, Renner W, Schmut O, Haas A: Haplotype-tagging interleukin-10 promoter polymorphism is associated with reduced risk of retinal artery occlusion.Mol Vis 2007;13:549-552.
10. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
11. Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, Martinson J, Ong'echa JM, Ferrell RE, Perkins DJ: Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet 2008;124:515-524.
12. Babel N, Gabdrakhmanova L, Hammer MH, Schoenemann C, Skrypnikov V, Poliak N, Volk HD, Reinke P: Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J Nephrol 2006;19:802-807.
13. Tsiavou A, Hatziagelaki E, Chaidaroglou A, Manginas A, Koniavitou K, Degiannis D, Raptis SA: TNF-alpha, TGFbeta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 2004;24:591-599.
14. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV: ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999;7:127-128.
15. Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R: Interleukin-8, monocyte chemoattractant protein- 1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med 2005;22:719-722.
16. Navarro JF, Mora-Fernández C: The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 2006;17:441-450.
17. Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R, Vergola D, Pinach S, Perin PC, Camussi G, Gruden G: Effect of the monocyte chemoattractant protein- 1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 2009;58:2109-2218
18. Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, Sytwu HK, Lin YF: Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta 2010;411:700-704.
19. Wang QY, Chen FQ: Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Diabetes Res Clin Pract 2009;83:215-219.
20. Van Exel E, Gussekloo J, de Craen AJ, Frö lich M, Bootsma- Van Der Wiel A, Westendorp RG: Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 2002;51:1088-1092.
21. Mtiraoui N, Ezzidi I, Kacem M, Ben Hadj Mohamed M, Chaieb M, Haj Jilani AB, Mahjoub T, Almawi WY: Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes Metab Res Rev 2009;25:57-63.
22. Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C: IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 2006;19:50-56.
23. Kucharzik T, Lü gering N, Pauels HG, Domschke W, Stoll R: IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol 1998;111:152-157.